Seraphim Space Investment Trust Reports Portfolio Progress Amid Capital Boost
Seraphim Space Investment Trust reports portfolio growth and lists new investments as its Class C shares rise.
Company news
Every story explained in plain English, with the prices that matter beside it.
Entera Bio Appoints Former Gilead Executive Laura Hamill to Board Ahead of Phase 3 Trial
Entera Bio Ltd. appointed former Gilead executive Laura Hamill to its board of directors as it prepares to launch a Phase 3 clinical trial for EB613.
AT&T Partners With GIP and CPP Investments for New Fiber Joint Venture
AT&T has agreed to create a wholesale fiber joint venture with GIP and CPP Investments to expand high-speed internet access across 16 states.
Amazon Web Services Expands AI Models as Run Rate Tops 25 Billion
Amazon Web Services grows its AI pipeline with new model launches, pushing its annual run rate past $25 billion despite high capital expenditures.
Rocket Pharmaceuticals Agrees with FDA on Trial Path for Danon Disease Therapy
Rocket Pharmaceuticals mapped out an FDA-aligned path to complete its pivotal Phase 2 trial of RP-A501, showing sustained activity in earlier tests.
Cadrenal Therapeutics Launches Strategic Review and Hires Tungsten Advisors
Cadrenal Therapeutics has launched a strategic review to maximize value, hiring Tungsten Advisors to evaluate licensing, asset sales, or partnerships.
Ondas Holdings Shares Trade at a Discount as Aggressive Defense Acquisitions Heighten Integration Risks
Ondas Holdings trades at a valuation discount compared to peers despite massive sales growth and a string of defense acquisitions.
Click Holdings Integrates Hong Kong Physiotherapy Clinic into Care U Platform
Click Holdings Limited is adding a physiotherapy clinic to its Care U platform, aiming to boost profit margins and expand services.
First Trust Launches FT Vest Laddered Autocallable Buffer and Resilient Income ETF
First Trust has launched a new actively managed ETF designed to provide fixed monthly distributions with a maturity buffer to limit downside equity risk.
Golar LNG Acquires Grace Dahlia Carrier for Conversion Into Fourth FLNG Vessel
Golar LNG Limited has agreed to buy the Grace Dahlia LNG carrier for conversion into its fourth FLNG unit, expanding its fleet capacity and storage.
Pearl Gold AG Appeal Dismissed in €927.9K Payment Dispute
The Higher Regional Court of Frankfurt dismissed an appeal against Pearl Gold AG, upholding a €927,932 payment order.
Company newsBullish
Pearl Gold AG Wins Appeal Against Former Board Member Over €927k Payment
Pearl Gold AG secured a legal victory as a German court upheld a €927,932 payment order against former board member Michael Reza Pacha.
Company newsBullish
IonQ Revenues Surge 132 Percent as Quantum Computing Competitors Advance New Systems
IonQ reported a 132 percent quarterly revenue increase, while competitor Quantum Computing Inc announced its new Dirac-3S machine.
Snowflake Shares Rise 34% in a Year on Accelerating AI Adoption
Snowflake shares have surged 34% over the past year, driven by rising AI adoption, growing product revenues, and an expanding customer base.
Morningstar Launches Global Browser-Based Direct AI Platform
Morningstar, Inc. launched Morningstar Direct AI globally, integrating AI agents with its research and ratings to expand its proprietary data tools.
TOP Ships to Acquire Four Tanker SPVs in Deal Adding $317M Potential Backlog
TOP Ships Inc. is acquiring four tanker SPVs, adding $317 million in potential backlog and extending its long-term charter strategy.
TOP Ships Acquires Four Ice Class Tankers to Grow Revenue Backlog to $1.24 Billion
TOP Ships Inc. is acquiring four newbuilding MR tankers, boosting its potential gross revenue backlog to an estimated $1.24 billion.
Pulse Biosciences Completes Enrollment for Atrial Fibrillation Study Ahead of Schedule
Pulse Biosciences completed enrollment for its NANOPULSE-AF clinical trial three months early to test its cardiac catheter system.
Coffee Holding Approves $2.5 Million Share Buyback Program
Coffee Holding Co., Inc. has authorized a $2.5 million share repurchase program funded by cash and operations as its stock surges.
BioCardia Shares CardiAMP HF II Trial Design as FDA Agrees Study May Support Approval
BioCardia presented its CardiAMP HF II trial design. The FDA agreed the study could support regulatory approval for the heart failure cell therapy.